FDA Inspection 1325676 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on June 11, 2026 in Medford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Medford, MA (United States)